Market Tracker

04/27 5:16pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

53.59
Delayed Data
As of 3:59pm ET
 +0.31 / +0.58%
Today’s Change
37.35
Today|||52-Week Range
55.15
+38.48%
Year-to-Date
Should You Make a Bet on the Healthcare Stocks?
Apr 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close53.28
Today’s open53.84
Day’s range53.43 - 54.10
Volume2,313,926
Average volume (3 months)1,294,900
Market cap$4.7B
Dividend yield--
Data as of 3:59pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)-55.24%
Earnings growth (this year)-39.98%
Earnings growth (next 5 years)-32.75%
Revenue growth (last year)-24.12%
P/E ratioNM
Price/Sales223.72
Price/Book14.70

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc-0.16-0.19%
TECHBio-Techne Corp+0.86+0.81%
BLUEbluebird bio Inc+0.40+0.45%
BIVVBioverativ Inc+0.15+0.26%
Data as of 3:59pm ET, 04/27/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$15.0M
Annual profit (last year)-$141.1M
Net profit margin-940.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
President, Chief Operating &
Financial Officer
David-Alexandre C. Gros
Corporate headquarters
San Diego, California

Forecasts